Are you Dr. Carter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr Msc 1881
Bldg 10 Rm 213
Bethesda, MD 20892Phone+1 301-496-8772Fax+1 301-480-8384
Summary
- Dr. Melody Carter, MD is an allergist/immunologist in Bethesda, Maryland. She is currently licensed to practice medicine in Georgia and Louisiana.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1999 - 2001
- Emory University School of MedicineResidency, Pediatrics, 1981 - 1984
- Tulane University School of MedicineClass of 1981
Certifications & Licensure
- GA State Medical License 1984 - 2025
- LA State Medical License 1981 - 1994
- American Board of Pediatrics Pediatrics
Clinical Trials
- Cause of Unexplained Anaphylaxis Start of enrollment: 2008 Nov 05
Publications & Presentations
PubMed
- 1 citationsHarmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose
The Journal of Allergy and Clinical Immunology. in Practice. 2024-12-01 - Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosis.Yuzhi Yin, Jenny Min Li, Dean D Metcalfe, Ana Olivera, Pamela A Frischmeyer-Guerrerio
The Journal of Allergy and Clinical Immunology. Global. 2024-11-01 - Mast cell activation syndrome: Current understanding and research needs.Mariana Castells, Matthew P Giannetti, Matthew J Hamilton, Peter Novak, Olga Pozdnyakova
The Journal of Allergy and Clinical Immunology. 2024-08-01
Press Mentions
- New Yardstick Offers Guidance for the Management and Diagnosis of Idiopathic AnaphylaxisSeptember 20th, 2019
- New Yardstick Offers Diagnostic and Treatment Guidance for Idiopathic AnaphylaxisSeptember 18th, 2019